Lataa...
A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system
Bispecific T-cell engagers (BiTEs) may break multiple barriers that currently limit the use of immunotherapy in glioblastoma patients. We have recently described a novel BiTE specific for a mutated form of the epidermal growth factor receptor, EGFRvIII, that exerts potent antineoplastic effects agai...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3654588/ https://ncbi.nlm.nih.gov/pubmed/23734318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23639 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|